Authors’ relationships and activities
Nordisk
RM is an employee of Boehringer Ingelheim Pharmaceuticals, Inc. AMH is an employee of Boehringer Ingelheim International GmbH. JH is an employee of Staburo GmbH, on behalf on Boehringer Ingelheim Pharma GmbH & Co. JR has served on advisory panels for Applied Therapeutics, Boehringer Ingelheim, Eli Lilly, Hanmi, Intarcia, Novo Nordisk, Oramed, Sanofi, Structure Therapeutics, Terns Pharma and Zealand; has received honoraria for lectures sponsored by Boehringer Ingelheim, Eli Lilly, Novo Nordisk and Sanofi; and has received research support from Applied Therapeutics, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Genentech, GlaxoSmithKline, Hanmi, Intarcia, Lexicon, Merck, Novartis, Novo Nordisk, Oramed, Pfizer and Sanofi. MB received honoraria as a consultant and speaker from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Lilly, Novartis, Novo Nordisk, Pfizer and Sanofi; and has participated on a data safety monitoring board/advisory board for Boehringer Ingelheim.